Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Brain Res. 2010 Sep 21;1361:93–101. doi: 10.1016/j.brainres.2010.09.025

Figure 6.

Figure 6

Western blot showing activated p44/42 MAPK and p70S6K (Thr421/Ser424) protein levels in neurons 24 hours after vehicle (lanes 1–3), PAR-1 agonist (50nM, lanes 4–6) or PAR-4 (50nM, lanes 7–9) agonist treatment. Values are mean ± SD, *p< 0.05, #p < 0.01 vs. vehicle-treated group.